XenaLives, high probability that PA has already been applied for and is in review considering the amount of data (showing positive results) available down under.
When time is right then the short string can be pulled! The P3 AD trial can be continued as a P4. Perhaps after the PDD READOUT! When ANAVEX can sell A 2-73 the REVENUE STREAM begins! Watch out!